Table 4.
Individual patient results during SL2 pilot trial
| Patient | Total hours | Num. measurements | Initial BG (mg/dL): | BG median [IQR] (mg/dL): | % BG within 80– 100 mg/dL | % BG within 100– 140 mg/dL | % BG within 140– 180 mg/dL | % BG ≥ 180 mg/ dL | % BG < 80 mg/ dL | % BG < 72 mg/ dL | % BG < 40 mg/ dL | Min BG level (mg/dL) | Median insulin rate [IQR] (U/h): | Max insulin rate (U/h): | Median glucose rate [IQR] (g/h): |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 |
23 |
11 |
118 |
118.0 [112.8 - 135.8] |
9.1 |
72.7 |
18.2 |
0 |
0 |
0 |
0 |
80 |
0.0 [0.0 - 1.0] |
2.0 |
0.0 [0.0 - 0.0] |
| 2 |
7 |
4 |
159 |
163.5 [142.5 - 204.0] |
0.0 |
25.0 |
50.0 |
25 |
0 |
0 |
0 |
126 |
0.3 [0.0 - 2.1] |
4.0 |
4.5 [0.3 - 4.5] |
| 3 |
23 |
9 |
164 |
137.0 [131.0 - 148.0] |
0.0 |
66.7 |
33.3 |
0 |
0 |
0 |
0 |
122 |
2.0 [2.0 - 2.5] |
3.0 |
0.0 [0.0 - 0.0] |
| 4 |
24 |
12 |
168 |
140.5 [130.5 - 146.0] |
0.0 |
50.0 |
50.0 |
0 |
0 |
0 |
0 |
109 |
2.7 [2.5 - 3.5] |
3.5 |
0.0 [0.0 - 0.0] |
| 5 |
23 |
11 |
223 |
148.0 [133.8 - 171.0] |
0.0 |
36.4 |
45.5 |
18.2 |
0 |
0 |
0 |
110 |
4.0 [2.5 - 4.5] |
6.0 |
5.6 [5.6 - 8.5] |
| 6 |
24 |
11 |
125 |
118.0 [107.0 - 125.8] |
9.1 |
72.7 |
18.2 |
0 |
0 |
0 |
0 |
82 |
0.0 [0.0 - 1.0] |
3.0 |
0.0 [0.0 - 0.0] |
| 7 |
23 |
11 |
138 |
138.0 [120.5 - 145.3] |
0.0 |
54.5 |
36.4 |
0 |
9.1 |
9.1 |
0 |
70 |
2.5 [1.7 - 3.0] |
4.0 |
5.4 [5.4 - 5.4] |
| 8 |
23 |
11 |
127 |
134.0 [103.8 - 169.0] |
9.1 |
45.5 |
36.4 |
9.1 |
0 |
0 |
0 |
97 |
1.0 [0.5 - 1.5] |
2.5 |
0.0 [0.0 - 0.0] |
| 9 | 24 | 11 | 155 | 121.0 [109.0 - 176.8] | 0.0 | 54.5 | 18.2 | 27.3 | 0 | 0 | 0 | 103 | 1.4 [1.0 - 1.9] | 3.0 | 2.0 [2.0 - 2.0] |